A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ESN364 in Healthy Japanese Male and Pre- and Post-menopausal Female Subjects

Authors Astellas Pharma Inc -More
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
Links ClinicalTrials.gov
The purpose of this study is to evaluate the safety and tolerability of single and multiple oral doses of ESN364 in healthy Japanese male and pre- and post-menopausal female subjects. This study will also evaluate the pharmacokinetics (PK) of ESN364 and its metabolite, and the pharmacodynamics (PD) of ESN364 after single and multiple oral doses administration in healthy Japanese male and pre- and post-menopausal female subjects.
Epistemonikos ID: f34c3573ea5c72ac3bd4fa9fa2b5490ec4ae3358
First added on: May 21, 2024